Abstract
We evaluated ocular surface alterations in allogeneic hematopoietic stem cell transplantation (HSCT) recipients with or without chronic GVHD-related dry eye in a prospective study. Fifty eyes of 25 post-HSCT patients and 28 eyes of 14 age-matched healthy controls were included. Meibomian gland (MG) obstruction, tear evaporation rate, corneal sensitivity (CS), Schirmer test-I, tear break-up time (BUT) and ocular surface vital staining were examined. Conjunctival impression and brush cytology specimens were collected to evaluate the goblet cell density (GCD) and the inflammatory cell numbers. Obvious MG obstruction, decreased CS and enhanced tear evaporation rate were found in post-HSCT patients compared with normal controls. In addition, decreased conjunctival GCD, increased conjunctival squamous metaplasia and inflammatory cells were noted in cGVHD-related dry eyes compared with normal controls and post-HSCT without dry eye subjects. Furthermore, the conjunctival inflammatory cells were significantly higher in severe dry eyes compared with mild dry eyes (P=0.03). We found comprehensive ocular surface alteration in post-HSCT patients, regardless of whether they had cGVHD-related dry eye or not. The results suggest that the extent of inflammatory process seems to have a pivotal role in the outcome of the cGVHD-related dry eye.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.
Ogawa Y, Okamoto S, Wakui M, Watanabe R, Yamada M, Yoshino M et al. Dry eye after hematopoietic stem cell transplantation. Br J Ophthalmol 1999; 83: 1125–1130.
Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanabe R et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003; 31: 579–583.
Ogawa Y, Yamazaki K, Kuwana M, Mashima Y, Nakamura Y, Ishida S et al. A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci 2001; 42: 111–119.
Ogawa Y, Kuwana M, Yamazaki K, Mashima Y, Yamada M, Mori T et al. Periductal area as the primary site for T-cell activation in lacrimal gland chronic graft-versus-host disease. Invest Ophthalmol Vis Sci 2003; 44: 1888–1896.
Rojas B, Cuhna R, Zafirakis P, Ramirez JM, Lizan-garciia M, Zhao T et al. Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation. Exp Eye Res 2005; 81: 313–325.
Singh R, Joseph A, Umapathy T, Tint NL, Dua HS . Impression cytology of the ocular surface. Br J Ophthalmol 2005; 89: 1655–1659.
Dogru M, Okada N, Asano-Kato N, Tanaka M, Igarashi A, Takano Y et al. Atopic ocular surface disease: implications on tear function and ocular surface mucins. Cornea 2005; 24: S18–S23.
Miyoshi T, Fukagawa K, Shimmura S, Fujishima H, Takano Y, Takamura E et al. Interleukin-8 concentrations in conjunctival epithelium brush cytology samples correlate with neutrophil, eosinophil infiltration, and corneal damage. Cornea 2001; 20: 743–747.
Aronni S, Cortes M, Sacchetti M, Lambiase A, Micera A, Sgrulletta R et al. Upregulation of ICAM-1 expression in the conjunctiva of patients with chronic graft-versus-host disease. Eur J Ophthalmol 2006; 16: 17–23.
Lemp MA . Report of the national eye institute/industry workshop on clinical trials in dry eyes. CLAO J 1995; 21: 221–232.
Report of the International Dry Eye Work Shop. Ocul Surf 2007; 5: 75–92.
Tsubota K . The importance of the Schirmer test with nasal stimulation test. Am J Ophthalmol 1991; 111: 106–108.
Toda I, Tsubota K . Practical double vital staining for ocular surface evaluation. Cornea 1993; 12: 366–368.
Dogru M, Asano-Kato N, Tanaka M, Igarashi A, Shimmura S, Shimazaki J et al. Ocular surface and MUC5AC alterations in atopic patients with corneal shield ulcers. Curr Eye Res 2005; 30: 897–908.
Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K . Meibomian gland dysfunction in patients with Sjogren syndrome. Ophthalmology 1998; 105: 1485–1488.
Goto E, Endo K, Suzuki A, Fujikura Y, Matsumoto Y, Tsubota K . Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2003; 44: 533–539.
Xu KP, Yagi Y, Tsubota K . Decrease in corneal sensitivity and change in tear function in dry eye. Cornea 1996; 15: 235–239.
Bourcier T, Acosta MC, Borderie V, Borrás F, Gallar J, Bury T et al. Decreased corneal sensitivity in patients with dry eye. Invest Ophthalmol Vis Sci 2005; 46: 2341–2345.
Nelson JD . Impression cytology. Cornea 1988; 7: 71–81.
McCulley JP, Shine WE . The lipid layer of tears: dependent on meibomian gland function. Exp Eye Res 2004; 78: 361–365.
Mathers W . Evaporation from the ocular surface. Exp Eye Res 2004; 78: 389–394.
Tseng SC . Staging of conjunctival squamous metaplasia by impression cytology. Ophthalmology 1985; 92: 728–733.
Aragona P, Ferreri G, Micali A, Puzzolo D . Morphological changes of the conjunctival epithelium in contact lens wearers evaluated by impression cytology. Eye 1998; 12: 461–466.
Tseng SC, Hirst LW, Maumenee AE, Kenyon KR, Sun TT, Green WR . Possible mechanisms for the loss of goblet cells in mucin-deficient disorders. Ophthalmology 1984; 91: 545–552.
Kinoshita S, Kiorpes TC, Friend J, Thoft RA . Goblet cell density in ocular surface disease. A better indicator than tear mucin. Arch Ophthalmol 1983; 101: 1284–1287.
Gipson IK, Hori Y, Argueso P . Character of ocular surface mucins and their alteration in dry eye disease. Ocul Surf 2004; 2: 131–147.
Stern ME, Pflugfelder SC . Inflammation in dry eye. Ocul Surf 2004; 2: 124–130.
Tsubota K, Fujihara T, Saito K, Takeuchi T . Conjunctival epithelium expression of HLA-DR in dry eye patients. Ophthalmologica 1999; 213: 16–19.
Rolando M, Barabino S, Mingari C, Moretti S, Giuffrida S, Calabria G . Distribution of conjunctival HLA-DR expression and the pathogenesis of damage in early dry eyes. Cornea 2005; 24: 951–954.
Acknowledgements
This work was presented in part at the 60th Japan Congress of Clinical Ophthalmology, 5–8 October 2006, Kyoto, Japan and ARVO 2007, Fort Lauderdale, USA. This work was supported by a grant from the Japanese Ministry of Education, Science, Sports and Culture #20592058.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Wang, Y., Ogawa, Y., Dogru, M. et al. Baseline profiles of ocular surface and tear dynamics after allogeneic hematopoietic stem cell transplantation in patients with or without chronic GVHD-related dry eye. Bone Marrow Transplant 45, 1077–1083 (2010). https://doi.org/10.1038/bmt.2009.312
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/bmt.2009.312
Keywords
This article is cited by
-
Long-term clinical outcomes and predictive factors in patients with chronic ocular graft-versus-host disease
Scientific Reports (2022)
-
Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study
Bone Marrow Transplantation (2021)
-
Regional Comparison of Goblet Cell Number and Area in Exposed and Covered Dry Eyes and Their Correlation with Tear MUC5AC
Scientific Reports (2020)
-
Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examination
Eye (2019)
-
Review of Biomarkers in Ocular Matrices: Challenges and Opportunities
Pharmaceutical Research (2019)